GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
An Air Canada Express regional jet crashed into a vehicle on the ground after landing at New York's LaGuardia Airport, forcing the airport to close....
Stocks look to be catching with BTC's earlier crash to nearly $60,000. ...
In the second round of the NCAA March Madness tournament, Iowa head coach Ben McCollum and Florida head coach Todd Golden ended up getting into verbal warfare....
